HBM Healthcare Investments (HBMN) - Total Assets
Based on the latest financial reports, HBM Healthcare Investments (HBMN) holds total assets worth CHF2.04 Billion CHF (≈ $2.58 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is HBM Healthcare Investments's book value for net asset value and shareholders' equity analysis.
HBM Healthcare Investments - Total Assets Trend (2002–2025)
This chart illustrates how HBM Healthcare Investments's total assets have evolved over time, based on quarterly financial data.
HBM Healthcare Investments - Asset Composition Analysis
Current Asset Composition (March 2025)
HBM Healthcare Investments's total assets of CHF2.04 Billion consist of 0.1% current assets and 99.9% non-current assets.
| Asset Category | Amount (CHF) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF2.48 Million | 0.1% |
| Accounts Receivable | CHF37.00K | 0.0% |
| Inventory | CHF0.00 | 0.0% |
| Property, Plant & Equipment | CHF0.00 | 0.0% |
| Intangible Assets | CHF0.00 | 0.0% |
| Goodwill | CHF0.00 | 0.0% |
Asset Composition Trend (2002–2025)
This chart illustrates how HBM Healthcare Investments's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see HBM Healthcare Investments (HBMN) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: HBM Healthcare Investments's current assets represent 0.1% of total assets in 2025, a decrease from 25.3% in 2002.
- Cash Position: Cash and equivalents constituted 0.1% of total assets in 2025, down from 25.3% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2002.
- Asset Diversification: The largest asset category is cash and equivalents at 0.1% of total assets.
HBM Healthcare Investments Competitors by Total Assets
Key competitors of HBM Healthcare Investments based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sprott Physical Gold Trust
TO:PHYS
|
Canada | CA$14.12 Billion |
|
Sprott Physical Silver
TO:PSLV
|
Canada | CA$9.40 Billion |
|
Reinet Investments S.C.A
AS:REINA
|
Netherlands | €6.66 Billion |
|
A.F.P. Provida
SN:PROVIDA
|
Chile | CL$1.39 Trillion |
|
Pinnacle Investment Management Group Ltd
AU:PNI
|
Australia | AU$1.07 Billion |
|
Kayne Anderson MLP Investment Closed Fund
NYSE:KYN
|
USA | $3.22 Billion |
|
Cuprum
SN:CUPRUM
|
Chile | CL$946.50 Billion |
|
Hainan Haide Industry Co Ltd
SHE:000567
|
China | CN¥8.60 Billion |
HBM Healthcare Investments - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.08 | 0.08 | 0.10 |
| Quick Ratio | 0.08 | 0.08 | 0.10 |
| Cash Ratio | 0.08 | 0.08 | 0.00 |
| Working Capital | CHF-69.23 Million | CHF-65.18 Million | CHF-54.54 Million |
HBM Healthcare Investments - Advanced Valuation Insights
This section examines the relationship between HBM Healthcare Investments's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.83 |
| Latest Market Cap to Assets Ratio | 0.88 |
| Asset Growth Rate (YoY) | -3.2% |
| Total Assets | CHF1.75 Billion |
| Market Capitalization | $1.53 Billion USD |
Valuation Analysis
Near Book Valuation: The market values HBM Healthcare Investments's assets close to their book value (0.88x), suggesting investors view the company's assets at approximately fair value.
Slight Asset Contraction: HBM Healthcare Investments's assets decreased by 3.2% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for HBM Healthcare Investments (2002–2025)
The table below shows the annual total assets of HBM Healthcare Investments from 2002 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | CHF1.75 Billion ≈ $2.21 Billion |
-3.24% |
| 2024-03-31 | CHF1.81 Billion ≈ $2.28 Billion |
-6.11% |
| 2023-03-31 | CHF1.92 Billion ≈ $2.43 Billion |
-9.98% |
| 2022-03-31 | CHF2.14 Billion ≈ $2.70 Billion |
-5.50% |
| 2021-03-31 | CHF2.26 Billion ≈ $2.86 Billion |
+45.72% |
| 2020-03-31 | CHF1.55 Billion ≈ $1.96 Billion |
+9.14% |
| 2019-03-31 | CHF1.42 Billion ≈ $1.80 Billion |
+12.83% |
| 2018-03-31 | CHF1.26 Billion ≈ $1.59 Billion |
+5.13% |
| 2017-03-31 | CHF1.20 Billion ≈ $1.52 Billion |
+6.80% |
| 2016-03-31 | CHF1.12 Billion ≈ $1.42 Billion |
-5.75% |
| 2015-03-31 | CHF1.19 Billion ≈ $1.51 Billion |
+28.68% |
| 2014-03-31 | CHF925.69 Million ≈ $1.17 Billion |
+53.77% |
| 2013-03-31 | CHF601.98 Million ≈ $761.07 Million |
+9.96% |
| 2012-03-31 | CHF547.46 Million ≈ $692.13 Million |
-12.87% |
| 2011-03-31 | CHF628.33 Million ≈ $794.38 Million |
-20.06% |
| 2010-03-31 | CHF785.96 Million ≈ $993.66 Million |
-2.90% |
| 2009-03-31 | CHF809.41 Million ≈ $1.02 Billion |
-28.82% |
| 2008-03-31 | CHF1.14 Billion ≈ $1.44 Billion |
-18.95% |
| 2007-03-31 | CHF1.40 Billion ≈ $1.77 Billion |
+33.08% |
| 2006-03-31 | CHF1.05 Billion ≈ $1.33 Billion |
+18.42% |
| 2005-03-31 | CHF890.18 Million ≈ $1.13 Billion |
+1.96% |
| 2004-03-31 | CHF873.02 Million ≈ $1.10 Billion |
+8.46% |
| 2003-03-31 | CHF804.91 Million ≈ $1.02 Billion |
+7.15% |
| 2002-03-31 | CHF751.19 Million ≈ $949.70 Million |
-- |
About HBM Healthcare Investments
HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public companies, buyouts, growth capital, and private investment in public equities (PIPES). Within fund of funds… Read more